Equioxx

RSS

firocoxib

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Equioxx.It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Equioxx.

For practical information about using Equioxx, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 09/08/2017

Authorisation details

Product details
Name
Equioxx
Agency product number
EMEA/V/C/000142
Active substance
firocoxib
International non-proprietary name (INN) or common name
firocoxib
Species
Horses
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AH90
Publication details
Marketing-authorisation holder
Ceva Sante Animale - Libourne
Revision
7
Date of issue of marketing authorisation valid throughout the European Union
25/06/2008
Contact address
10 avenue de la Ballastière
33500 Libourne
France

Product information

29/06/2017 Equioxx - EMEA/V/C/000142 - T/0019

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Anti inflammatory and antirheumatic products

Therapeutic indication

Alleviation of pain and inflammation associated with osteoarthritis and reduction of associated lameness in horses.

Assessment history

How useful was this page?

Add your rating